Literature DB >> 23110866

Mild cognitive impairment in a community sample: the Sydney Memory and Ageing Study.

Henry Brodaty1, Megan Heffernan, Nicole A Kochan, Brian Draper, Julian N Trollor, Simone Reppermund, Melissa J Slavin, Perminder S Sachdev.   

Abstract

BACKGROUND: Mild cognitive impairment (MCI) is associated with an increased dementia risk. This study reports incidence of MCI subtypes, rates of progression to dementia, and stability of MCI classification.
METHODS: We examined 873 community-dwelling adults aged 70 to 90 years over 2 years as part of an ongoing population-based longitudinal study, the Sydney Memory and Ageing Study. Neuropsychological testing assessed five cognitive domains, and a diagnosis of no cognitive impairment, MCI, or dementia (follow-up only) was made according to published criteria.
RESULTS: The incidence of MCI was 104.6 (95% confidence interval: 81.6-127.7) per 1000 person-years, with higher incidence in men (men, 156.8; women, 70.3). Incidence rates for single-domain amnestic, multiple-domain amnestic, single-domain nonamnestic, and multiple-domain nonamnestic MCI were 47.7, 7.9, 45.0, and 3.9 per 1000 person-years, respectively. The 2-year rate of progression from MCI at baseline to dementia was 4.8%, being highest for multidomain amnestic MCI (9.1%). Of those with MCI at baseline, 28.2% reverted to no cognitive impairment at follow-up. Sensitivity analyses by redefining criteria for cognitive impairment did not affect stability of diagnosis, although changing the threshold of domain impairment reduced baseline MCI prevalence from 36.7% to 5.7% and incidence to 23.5, and increased 2-year progression rate from MCI to dementia to 14.3%.
CONCLUSIONS: Incidence rates for MCI are higher than previously reported, particularly in men and for single-domain MCI; rates for amnestic and nonamnestic MCI were comparable. Multidomain amnestic MCI was the most likely subtype to progress to dementia, but overall, the diagnosis of MCI, particularly single-domain MCI, shows considerable instability.
Copyright © 2012 The Alzheimer's Association. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 23110866     DOI: 10.1016/j.jalz.2011.11.010

Source DB:  PubMed          Journal:  Alzheimers Dement        ISSN: 1552-5260            Impact factor:   21.566


  39 in total

1.  Simulating effects of biomarker enrichment on Alzheimer's disease prevention trials: conceptual framework and example.

Authors:  Jeannie-Marie S Leoutsakos; Alexandra L Bartlett; Sarah N Forrester; Constantine G Lyketsos
Journal:  Alzheimers Dement       Date:  2013-08-15       Impact factor: 21.566

2.  A point-based tool to predict conversion from mild cognitive impairment to probable Alzheimer's disease.

Authors:  Deborah E Barnes; Irena S Cenzer; Kristine Yaffe; Christine S Ritchie; Sei J Lee
Journal:  Alzheimers Dement       Date:  2014-02-01       Impact factor: 21.566

Review 3.  Clinical workout for the early detection of cognitive decline and dementia.

Authors:  M Tsolaki
Journal:  Eur J Clin Nutr       Date:  2014-10-01       Impact factor: 4.016

4.  Better verbal memory in women than men in MCI despite similar levels of hippocampal atrophy.

Authors:  Erin E Sundermann; Anat Biegon; Leah H Rubin; Richard B Lipton; Wenzhu Mowrey; Susan Landau; Pauline M Maki
Journal:  Neurology       Date:  2016-03-16       Impact factor: 9.910

5.  Sex-specific norms for verbal memory tests may improve diagnostic accuracy of amnestic MCI.

Authors:  Erin E Sundermann; Pauline Maki; Anat Biegon; Richard B Lipton; Michelle M Mielke; Mary Machulda; Mark W Bondi
Journal:  Neurology       Date:  2019-10-09       Impact factor: 9.910

6.  The Effects and Meanings of Receiving a Diagnosis of Mild Cognitive Impairment or Alzheimer's Disease When One Lives Alone.

Authors:  Elena Portacolone; Julene K Johnson; Kenneth E Covinsky; Jodi Halpern; Robert L Rubinstein
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

7.  MEG spectral analysis in subtypes of mild cognitive impairment.

Authors:  M E López; P Cuesta; P Garcés; P N Castellanos; S Aurtenetxe; R Bajo; A Marcos; M L Delgado; P Montejo; J L López-Pantoja; F Maestú; A Fernandez
Journal:  Age (Dordr)       Date:  2014-02-16

8.  Female advantage in verbal memory: Evidence of sex-specific cognitive reserve.

Authors:  Erin E Sundermann; Pauline M Maki; Leah H Rubin; Richard B Lipton; Susan Landau; Anat Biegon
Journal:  Neurology       Date:  2016-10-05       Impact factor: 9.910

9.  Factors predicting reversion from mild cognitive impairment to normal cognitive functioning: a population-based study.

Authors:  Perminder S Sachdev; Darren M Lipnicki; John Crawford; Simone Reppermund; Nicole A Kochan; Julian N Trollor; Wei Wen; Brian Draper; Melissa J Slavin; Kristan Kang; Ora Lux; Karen A Mather; Henry Brodaty
Journal:  PLoS One       Date:  2013-03-27       Impact factor: 3.240

10.  The effect of increased genetic risk for Alzheimer's disease on hippocampal and amygdala volume.

Authors:  Michelle K Lupton; Lachlan Strike; Narelle K Hansell; Wei Wen; Karen A Mather; Nicola J Armstrong; Anbupalam Thalamuthu; Katie L McMahon; Greig I de Zubicaray; Amelia A Assareh; Andrew Simmons; Petroula Proitsi; John F Powell; Grant W Montgomery; Derrek P Hibar; Eric Westman; Magda Tsolaki; Iwona Kloszewska; Hilkka Soininen; Patrizia Mecocci; Bruno Velas; Simon Lovestone; Henry Brodaty; David Ames; Julian N Trollor; Nicholas G Martin; Paul M Thompson; Perminder S Sachdev; Margaret J Wright
Journal:  Neurobiol Aging       Date:  2016-01-11       Impact factor: 4.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.